- Trials with a EudraCT protocol (82)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
82 result(s) found for: Falling.
Displaying page 1 of 5.
EudraCT Number: 2006-001040-31 | Sponsor Protocol Number: TUD-RELAZA-008 | Start Date*: 2006-11-23 |
Sponsor Name:University of Technology Dresden | ||
Full Title: Treatment of the haematological relapse in patients suffering from acute myeloid leukaemia or myelodysplastic syndrome with 5-Azacytidin (Vidaza®) after hematopoietic stem cell transplantation "REL... | ||
Medical condition: Patients suffering from acute myeloid leukaemia or myelodysplastic syndrome with falling CD34-chimerism or relapse after hematopoietic stem cell transplantation. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-002661-36 | Sponsor Protocol Number: 15039DB-SW | Start Date*: 2016-03-10 |
Sponsor Name:Belfast Health and Social Care Trust | ||
Full Title: Single centre randomised controlled trial to assess the effect of the addition of twenty-four hours of oral tranexamic acid post-operatively to a single intra-operative intravenous dose of tranexam... | ||
Medical condition: Osteoarthritic patients who require hip or knee arthroplasty | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-004664-46 | Sponsor Protocol Number: melmet | Start Date*: 2008-07-29 |
Sponsor Name:No Sponsor | ||
Full Title: Influence of methylphenidate on sleep and circadian rhythm in children with Attention-Deficit/Hyperactivity Disorder (ADHD) | ||
Medical condition: Sleep disorders in Attention-Deficit/ Hyperactivity Disorder (ADHD) | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-000303-28 | Sponsor Protocol Number: MW029 | Start Date*: 2014-09-29 | |||||||||||
Sponsor Name:Dr. Willmar Schwabe GmbH & Co. KG | |||||||||||||
Full Title: Multi-center, prospective, controlled, randomized, single-blinded study to evaluate the efficacy of vibrotactile neuro-feedback additionally to intake of Ginkgo biloba special extract EGb 761® for ... | |||||||||||||
Medical condition: Presby Vertigo | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-001548-23 | Sponsor Protocol Number: 20124444 | Start Date*: 2012-11-28 |
Sponsor Name:ParnassiaBavoGroup | ||
Full Title: An open label study with objective sleepregistration on the effects of Doxazosin as treatment for PTSD, especially for sleep disturbance | ||
Medical condition: Posttraumatic stress disorder | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-003460-31 | Sponsor Protocol Number: COP13.058 | Start Date*: 2014-03-03 |
Sponsor Name:GGZ-Drenthe | ||
Full Title: The effect of low doses of mirtazapine and quetiapine on sleep and daytime functioning. | ||
Medical condition: Insomnia | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-000606-11 | Sponsor Protocol Number: 5502071979 | Start Date*: Information not available in EudraCT |
Sponsor Name:Region Ostergotland | ||
Full Title: Melatonin compared to sleep deprivation for sleep EEG recordings in children: impact on epileptiform discharges and sleep, contributing factors on the results and the influence on children's and pa... | ||
Medical condition: suspected epilepsy | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2019-004766-17 | Sponsor Protocol Number: zoledronate-fract-65-85yr | Start Date*: 2021-06-30 |
Sponsor Name:Region Uppsala | ||
Full Title: The Fragility Fracture Trial (FFT): A randomized, double-blind, placebo-controlled trial to investigate whether zoledronic acid prevents new fractures in older adults with a recent non-hip, non-ver... | ||
Medical condition: Non-hip, non-vertebral fragility fracture | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2019-000203-33 | Sponsor Protocol Number: 9119 | Start Date*: 2019-10-16 | |||||||||||
Sponsor Name:Klinisk Farmakologisk Afdeling | |||||||||||||
Full Title: Paracetamol Discontinuation in the Elderly after long-term consumption (PARADISE) | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-003219-23 | Sponsor Protocol Number: 2844 | Start Date*: 2019-06-28 | ||||||||||||||||
Sponsor Name:University of Bristol | ||||||||||||||||||
Full Title: CHIEF-PD (CHolinesterase Inhibitor to prEvent Falls in Parkinson’s Disease): A phase 3 randomised double-blind placebo-controlled trial of rivastigmine to prevent falls in Parkinson’s disease | ||||||||||||||||||
Medical condition: This trial will investigate the effectiveness of Rivastigmine on prevention of falls in patients with Parkinson's disease | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-004920-40 | Sponsor Protocol Number: AFFECT | Start Date*: 2021-03-22 |
Sponsor Name:Vestre Viken HF | ||
Full Title: Affective effects of pre-surgery opioids (AFFECT): a randomized double-blind controlled trial | ||
Medical condition: Healthy adult surgery patients. Health status ASA1 or ASA2 as categorised by a medical doctor at the hospital based on medical history, physical examination. The American Society of Anesthesiologis... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NO (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-000122-26 | Sponsor Protocol Number: 125591 | Start Date*: 2020-05-11 | |||||||||||
Sponsor Name:University College London (UCL) | |||||||||||||
Full Title: A Phase IIa, open label, single-site, 48 week randomised controlled trial evaluating the safety and efficacy of Exenatide once-weekly in the treatment of patients with Multiple System Atrophy | |||||||||||||
Medical condition: Multiple System Atrophy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-004207-22 | Sponsor Protocol Number: CLCZ696B2319 | Start Date*: 2017-04-06 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: Multicenter, open-label, study to evaluate safety, tolerability, pharmacokinetics and, pharmacodynamics of LCZ696 followed by a 52-week randomized, double-blind, parallel group, active-controlled s... | |||||||||||||
Medical condition: Pediatric heart failure 1 month to <18 years old | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) FI (Completed) NL (Ongoing) SE (Completed) NO (Completed) ES (Completed) GB (GB - no longer in EU/EEA) CZ (Completed) IT (Completed) FR (Completed) BG (Completed) PL (Completed) HU (Completed) HR (Completed) AT (Completed) PT (Completed) RO (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-001705-42 | Sponsor Protocol Number: CRB-MNX-08-01 | Start Date*: 2008-06-04 | |||||||||||
Sponsor Name:L'OREAL | |||||||||||||
Full Title: ETUDE TRANSCRIPTOMIQUE DE LA REPONSE AU MINOXIDIL CHEZ L'HOMME ALOPECIQUE | |||||||||||||
Medical condition: alopécie androgénétique | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-001584-36 | Sponsor Protocol Number: 2014-03-11 | Start Date*: 2016-06-01 |
Sponsor Name:Universitetssjukhuset Örebro | ||
Full Title: Is high oxygen concentration a riskfactor for postoperative complications? A prospective, randomized, singel blinded study in elderly patients undergoing vascular surgery | ||
Medical condition: Elective vascular surgery (peripheral vascular and aortic surgery) | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-001496-21 | Sponsor Protocol Number: LOC-2013 | Start Date*: 2013-06-18 |
Sponsor Name:Harry Scheinin | ||
Full Title: The Neural Mechanisms of Anesthesia and Human Consciousness | ||
Medical condition: No medical condition or disease involved. The study subjects are healthy volunteers. | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: FI (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2013-001731-40 | Sponsor Protocol Number: UMCN-ONCO-201301 | Start Date*: 2013-08-26 | |||||||||||
Sponsor Name:Radboud University Nijmegen Medical Centre | |||||||||||||
Full Title: Influence of exceptional patient characteristics on everolimus exposure | |||||||||||||
Medical condition: breast cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-004368-23 | Sponsor Protocol Number: 20121005 | Start Date*: 2012-11-02 | |||||||||||
Sponsor Name:Odense University Hospital | |||||||||||||
Full Title: Feasible strategy for preventing blood clots in critically ill patients with acute kidney Injury | |||||||||||||
Medical condition: venous thromboembolism | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-005443-23 | Sponsor Protocol Number: FEMTIB2020 | Start Date*: 2021-06-21 |
Sponsor Name:Hospital Sant Joan de Reus | ||
Full Title: Comparative study between two ultrasound-guided peripheral blocks for postoperative analgesia of primary total knee arthroplasty | ||
Medical condition: Patients undergoing knee replacement | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-006085-40 | Sponsor Protocol Number: 2011-006085-40 | Start Date*: 2012-12-17 |
Sponsor Name:Cliniques Universitaires Saint Luc | ||
Full Title: A proof of concept study to evaluate the use of metabonomics and lipidomics in predicting toxicity and efficacy of anti-VEGF therapy in patients with metastatic clear cell renal cell carcinoma. | ||
Medical condition: Metastatic clear cell renal cell carcinoma | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
